source Post navigation 2 Biotech Stocks That Could Soar in December – The Motley Fool Biomea Fusion Announces Acceptance of Three Abstracts for its Novel Menin Inhibitor Highlighting Durable Glycemic Control in Diabetes Patients at the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in 2024 – Yahoo Finance